Literature DB >> 26425994

HDL cholesterol and stroke risk: The Multi-Ethnic Study of Atherosclerosis.

Samantha A Reina1, Maria M Llabre2, Matthew A Allison3, John T Wilkins4, Armando J Mendez5, Martinson K Arnan6, Neil Schneiderman2, Ralph L Sacco5, Mercedes Carnethon4, J A Chris Delaney7.   

Abstract

BACKGROUND AND
PURPOSE: Accurate identification of risk factors for stroke is important for public health promotion and disease prevention. HDL cholesterol is a potential risk factor, yet its role in stroke risk is unclear, as is whether HDL cholesterol content or particle number might be a better indicator of stroke risk. Furthermore, the degree to which ethnicity moderates the risk is unknown. As such, the current study examines the associations between incident stroke and both HDL cholesterol concentration and particle number, and assesses the moderating role of race and ethnicity.
METHODS: The sample is a racially diverse cohort of US adults between the ages of 45-84 years enrolled in the Multi-Ethnic Study of Atherosclerosis between 2000 and 2002 and followed until December 2011. The associations among cholesterol content and stroke risk, particle number and stroke risk, and the interaction with race were explored.
RESULTS: The incidence of stroke was 2.6%. HDL cholesterol concentration (mmol/L) (Hazard Ratio (HR) = .56; 95% Confidence Interval (CI): .312-.988) and number of large HDL particles (μmol/L) (HR = .52, CI: .278-.956) were associated with lower stroke risk. When interactions with race were evaluated, the relationship between both HDL variables and stroke were significant in Blacks, but not other races.
CONCLUSIONS: Higher HDL cholesterol and a higher concentration of large particles are associated with lower risk of stroke in Blacks. Further research is needed to elucidate the mechanisms by which HDL subfractions may differentially affect stroke outcome in different races/ethnicities.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cholesterol; Lipids; Risk factors for stroke

Mesh:

Substances:

Year:  2015        PMID: 26425994      PMCID: PMC4609625          DOI: 10.1016/j.atherosclerosis.2015.09.031

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  35 in total

Review 1.  High-density lipoprotein--the clinical implications of recent studies.

Authors:  D J Gordon; B M Rifkind
Journal:  N Engl J Med       Date:  1989-11-09       Impact factor: 91.245

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

Review 3.  Physical activity and the incidence of coronary heart disease.

Authors:  K E Powell; P D Thompson; C J Caspersen; J S Kendrick
Journal:  Annu Rev Public Health       Date:  1987       Impact factor: 21.981

4.  Cardiovascular risk factors and impaired glucose tolerance: the San Luis Valley Diabetes Study.

Authors:  C M Burchfiel; R F Hamman; J A Marshall; J Baxter; L B Kahn; J J Amirani
Journal:  Am J Epidemiol       Date:  1990-01       Impact factor: 4.897

5.  Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen City Heart Study.

Authors:  E Lindenstrøm; G Boysen; J Nyboe
Journal:  BMJ       Date:  1994-07-02

6.  Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice.

Authors:  C Pászty; N Maeda; J Verstuyft; E M Rubin
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

7.  Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.

Authors:  E M Rubin; R M Krauss; E A Spangler; J G Verstuyft; S M Clift
Journal:  Nature       Date:  1991-09-19       Impact factor: 49.962

8.  Multi-Ethnic Study of Atherosclerosis: objectives and design.

Authors:  Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy
Journal:  Am J Epidemiol       Date:  2002-11-01       Impact factor: 4.897

Review 9.  Regulation of reverse cholesterol transport and clinical implications.

Authors:  Daniel J Rader
Journal:  Am J Cardiol       Date:  2003-08-18       Impact factor: 2.778

10.  The role of behavioral variables and fat patterning in explaining ethnic differences in serum lipids and lipoproteins.

Authors:  S M Haffner; M P Stern; H P Hazuda; M Rosenthal; J A Knapp
Journal:  Am J Epidemiol       Date:  1986-05       Impact factor: 4.897

View more
  20 in total

1.  Inverse Association Between HDL (High-Density Lipoprotein) Cholesterol and Stroke Risk Among Patients With Type 2 Diabetes Mellitus.

Authors:  Yun Shen; Lizheng Shi; Elizabeth Nauman; Peter T Katzmarzyk; Eboni G Price-Haywood; Alessandra N Bazzano; Somesh Nigam; Gang Hu
Journal:  Stroke       Date:  2019-02       Impact factor: 7.914

2.  Postprandial remodeling of high-density lipoprotein following high saturated fat and high carbohydrate meals.

Authors:  Michelle Averill; Katya B Rubinow; Kevin Cain; Jake Wimberger; Ilona Babenko; Jessica O Becker; Karen E Foster-Schubert; David E Cummings; Andrew N Hoofnagle; Tomas Vaisar
Journal:  J Clin Lipidol       Date:  2019-11-22       Impact factor: 4.766

Review 3.  Drug Therapy of Dyslipidemia in the Elderly.

Authors:  Srikanth Yandrapalli; Shashvat Gupta; Gabriela Andries; Howard A Cooper; Wilbert S Aronow
Journal:  Drugs Aging       Date:  2019-04       Impact factor: 3.923

Review 4.  The Different Facets of Dyslipidemia and Hypertension in Atherosclerosis.

Authors:  Jessica Hurtubise; Krystie McLellan; Kevin Durr; Oluwadara Onasanya; Daniel Nwabuko; Joseph Fomusi Ndisang
Journal:  Curr Atheroscler Rep       Date:  2016-12       Impact factor: 5.113

5.  Impact of TLR5 rs5744174 on stroke risk, gene expression and on inflammatory cytokines, and lipid levels in stroke patients.

Authors:  Lian Gu; Jingyan Huang; Jinjing Tan; Qiugui Wei; Haiyun Jiang; Tingting Shen; Baoyun Liang; Nong Tang
Journal:  Neurol Sci       Date:  2016-06-04       Impact factor: 3.307

6.  Additive interaction between potentially modifiable risk factors and ethnicity among individuals in the Han, Tujia and Miao populations with first-ever ischaemic stroke.

Authors:  Na Zhang; Xinrui Wu; Mengyuan Tian; Xiaolei Wang; Jian Ding; Yong Tian; Chengcai Liang; Zhi Zeng; Hua Xiang; Hongzhuan Tan
Journal:  BMC Public Health       Date:  2021-06-03       Impact factor: 3.295

Review 7.  The Endothelium Is Both a Target and a Barrier of HDL's Protective Functions.

Authors:  Jérôme Robert; Elena Osto; Arnold von Eckardstein
Journal:  Cells       Date:  2021-04-28       Impact factor: 6.600

8.  High-Density Lipoprotein Carries Markers That Track With Recovery From Stroke.

Authors:  Deanna L Plubell; Alex M Fenton; Sara Rosario; Paige Bergstrom; Phillip A Wilmarth; Wayne M Clark; Neil A Zakai; Joseph F Quinn; Jessica Minnier; Nabil J Alkayed; Sergio Fazio; Nathalie Pamir
Journal:  Circ Res       Date:  2020-08-26       Impact factor: 17.367

9.  Delayed retinal vein recovery responses indicate both non-adaptation to stress as well as increased risk for stroke: the SABPA study.

Authors:  Leoné Malan; Mark Hamer; Roland von Känel; Konstantin Kotliar; Roelof D van Wyk; Gavin W Lambert; Walthard Vilser; Tjalf Ziemssen; Markus P Schlaich; Wayne Smith; Martin Magnusson; Annemarie Wentzel; Carlien E Myburgh; Hendrik S Steyn; Nico T Malan
Journal:  Cardiovasc J Afr       Date:  2020-10-26       Impact factor: 1.167

10.  The association between serine hydroxymethyl transferase 1 gene hypermethylation and ischemic stroke.

Authors:  Junnan Wang; Junqing Gu; Yi Huang; Yuanjian Fang; Jinhui Lin
Journal:  Bosn J Basic Med Sci       Date:  2021-08-01       Impact factor: 3.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.